• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

non-small cell lung cancer (NSCLC) - Articles and news items

assay

FDA approves Roche’s immunotherapy assay to support treatment decisions in lung cancer

Industry news / 31 October 2016 / Niamh Louise Marriott, Digital Content Producer

The US Food and Drug Administration (FDA) has approved Roche’s PD-L1 assay as a diagnostic to identify PD-L1 expression levels in patients considering treatment with Tecentriq (atezolizumab) for previously treated metastatic non-small cell lung cancer (NSCLC). The PD-L1 (SP142) assay is also indicated to identify patients with urothelial cancer (UC) who may benefit from treatment […]

did-not-meet-primary-endpoint

OncoGenex’s Phase 3 non-small cell lung cancer trial did not meet primary endpoint

Industry news / 14 October 2016 / Niamh Louise Marriott, Digital Content Producer

OncoGenex’ results, analysed from the Phase 3 trial of custirsen in patients whose non-small cell lung cancer (NSCLC) has progressed following initial…

bristol-myers-sqibb-cdf

NICE says CDF case for nivolumab to treat lung cancer is not clear cut

Industry news / 14 October 2016 / Niamh Louise Marriott, Digital Content Producer

NICE’s appraisal committee concluded that nivolumab was not cost-effective for all patients in the treatment of non small-cell lung cancer…

stancell-scib2-lung-cancer

Scancell preparing SCIB2 for clinical study in lung cancer

Industry news / 13 October 2016 / Niamh Louise Marriott, Digital Content Producer

Scancell intends to develop its SCIB2 ImmunoBody for the treatment of non-small cell lung cancer (NSCLC) in combination with a checkpoint inhibitor…

scotland-nhs-lung-cancer

Scotland speeds ahead to deliver breakthrough immunotherapy to lung cancer patients 

Industry news / 11 October 2016 / Niamh Louise Marriott, Digital Content Producer

This recommendation means that patients in Scotland will become the first in the UK to be treated with nivolumab on the NHS…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +